HeartSciences Says As Of April 30, 2024, Cash And Cash Equivalents Were ~$5.8M And Shareholders' Equity Was Approximately $7.3M
HeartSciences Says As Of April 30, 2024, Cash And Cash Equivalents Were ~$5.8M And Shareholders' Equity Was Approximately $7.3M
HeartSciences表示，截至2024年4月30日，現金及現金等價物約爲580萬美元，股東權益約爲約730萬美元。
HeartSciences Says As Of April 30, 2024, Cash And Cash Equivalents Were ~$5.8M And Shareholders' Equity Was Approximately $7.3M
HeartSciences表示，截至2024年4月30日，現金及現金等價物約爲580萬美元，股東權益約爲約730萬美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。